{"transactions":[{"id":4219929,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":false,"shares":695,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":11.1,"exercise_date":"2009-03-26","expiration_date":"2019-02-26","underlying":"Common Stock","underlying_shares":695},"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":45,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219928,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":false,"shares":694,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":695,"derivative":{"exercise_price":11.1,"exercise_date":"2009-03-26","expiration_date":"2019-02-26","underlying":"Common Stock","underlying_shares":694},"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":44,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219927,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":false,"shares":11552,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9.65,"exercise_date":"2014-03-24","expiration_date":"2024-02-24","underlying":"Common Stock","underlying_shares":11552},"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":43,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219926,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":false,"shares":617,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9.42,"exercise_date":"2011-03-28","expiration_date":"2021-02-28","underlying":"Common Stock","underlying_shares":617},"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":42,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219925,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":false,"shares":15206,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3750,"derivative":{"exercise_price":7.96,"exercise_date":"2015-03-26","expiration_date":"2025-02-26","underlying":"Common Stock","underlying_shares":15206},"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":41,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219924,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":false,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14517,"derivative":{"exercise_price":6.67,"exercise_date":"2016-03-23","expiration_date":"2026-02-23","underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":40,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219923,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":false,"shares":1079,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":6.3,"exercise_date":"2012-04-05","expiration_date":"2022-03-05","underlying":"Common Stock","underlying_shares":1079},"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":39,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219922,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":false,"shares":3795,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":6,"exercise_date":"2013-04-05","expiration_date":"2023-03-05","underlying":"Common Stock","underlying_shares":3795},"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":38,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219921,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":false,"shares":2638,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":11.1,"exercise_date":"2009-03-26","expiration_date":"2019-02-26","underlying":"Common Stock","underlying_shares":2638},"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":37,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219920,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":false,"shares":2639,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2638,"derivative":{"exercise_price":11.1,"exercise_date":"2009-03-26","expiration_date":"2019-02-26","underlying":"Common Stock","underlying_shares":2639},"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":36,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219919,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":false,"shares":13448,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5000,"derivative":{"exercise_price":9.65,"exercise_date":"2014-03-24","expiration_date":"2024-02-24","underlying":"Common Stock","underlying_shares":13448},"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":35,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219918,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":false,"shares":11883,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9.42,"exercise_date":"2011-03-28","expiration_date":"2021-02-28","underlying":"Common Stock","underlying_shares":11883},"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":34,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219917,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":false,"shares":2294,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8750,"derivative":{"exercise_price":7.96,"exercise_date":"2015-03-26","expiration_date":"2025-02-26","underlying":"Common Stock","underlying_shares":2294},"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":33,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219916,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":false,"shares":13920,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":6.3,"exercise_date":"2012-04-05","expiration_date":"2022-03-05","underlying":"Common Stock","underlying_shares":13920},"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":32,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219915,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":false,"shares":21204,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":6,"exercise_date":"2013-04-05","expiration_date":"2023-03-05","underlying":"Common Stock","underlying_shares":21204},"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":31,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219914,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":2638,"price":15,"value":39570.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":46441,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219913,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":true,"shares":2638,"price":11.1,"value":29281.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":49079,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219912,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":695,"price":15,"value":10425.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":46441,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219911,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":true,"shares":695,"price":11.1,"value":7714.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":47136,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219910,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":2639,"price":15,"value":39585.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":46441,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219909,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":true,"shares":2639,"price":11.1,"value":29292.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":49080,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219908,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":694,"price":15,"value":10410.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":46441,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219907,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":true,"shares":694,"price":11.1,"value":7703.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":47135,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219906,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":11883,"price":15,"value":178245.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":46441,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219905,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":true,"shares":11883,"price":9.42,"value":111937.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":58324,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219904,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":617,"price":15,"value":9255.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":46441,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219903,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":true,"shares":617,"price":9.42,"value":5812.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":47058,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219902,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":13920,"price":15,"value":208800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":46441,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219901,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":true,"shares":13920,"price":6.3,"value":87696.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":60361,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219900,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":1079,"price":15,"value":16185.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":46441,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219899,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":true,"shares":1079,"price":6.3,"value":6797.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":47520,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219898,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":21204,"price":15,"value":318060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":46441,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219897,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":true,"shares":21204,"price":6,"value":127224.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":67645,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219896,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":3795,"price":15,"value":56925.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":46441,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219895,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":true,"shares":3795,"price":6,"value":22770.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":50236,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219894,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":13448,"price":15,"value":201720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":46441,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219893,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":true,"shares":13448,"price":9.65,"value":129773.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":59889,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219892,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":11552,"price":15,"value":173280.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":46441,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219891,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":true,"shares":11552,"price":9.65,"value":111476.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":57993,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219890,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":2294,"price":15,"value":34410.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":46441,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219889,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":true,"shares":2294,"price":7.96,"value":18260.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":48735,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219888,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":15206,"price":15,"value":228090.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":46441,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219887,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":true,"shares":15206,"price":7.96,"value":121039.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":61647,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219886,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":16666,"price":15,"value":249990.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":46441,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4219885,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-09-01T23:20:43.000Z","date":"2017-08-31","kind":"exercise","acquired":true,"shares":16666,"price":6.67,"value":111162.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017."}],"balance_after":63107,"source":{"system":"sec-edgar","filing":"0001061983-17-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000052/edgardoc.xml","form_type":"4"}},{"id":4410676,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-03-03T00:06:27.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":13537,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"When the ISO and NQ dated 02/28/2017 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/28/2021."}],"balance_after":13537,"derivative":{"exercise_price":10.6,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":13537},"source":{"system":"sec-edgar","filing":"0001061983-17-000017","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000017/edgardoc.xml","form_type":"4"}},{"id":4410675,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-03-03T00:06:27.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":6463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"When the ISO and NQ dated 02/28/2017 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/28/2021."}],"balance_after":6463,"derivative":{"exercise_price":10.6,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":6463},"source":{"system":"sec-edgar","filing":"0001061983-17-000017","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000017/edgardoc.xml","form_type":"4"}},{"id":4410674,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-03-03T00:06:27.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":20000,"price":0.001,"value":20.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The restricted stock units vest in three annual installments.  Vested shares will be delivered to the reporting person as follows: 40% on 02/28/2018, 40% on 02/28/2019 and 20% on 02/28/2020."}],"balance_after":45194,"source":{"system":"sec-edgar","filing":"0001061983-17-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000017/edgardoc.xml","form_type":"4"}},{"id":4410673,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-03-03T00:06:27.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":5986,"price":10.6,"value":63451.6,"ownership":{"direct":true},"balance_after":25194,"source":{"system":"sec-edgar","filing":"0001061983-17-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000017/edgardoc.xml","form_type":"4"}},{"id":4410672,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":173437,"kind":"person","name":"Morgan Bradley Paul","position":1,"cik":"0001659025","reported_name":"Morgan Bradley Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Drug Discovery & Early Dev"}}],"security":"Common Stock","published_at":"2017-03-03T00:06:27.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":15000,"price":0.001,"value":15.0,"ownership":{"direct":true},"balance_after":31180,"source":{"system":"sec-edgar","filing":"0001061983-17-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000017/edgardoc.xml","form_type":"4"}}]}